Suppr超能文献

[具体物质]对人类病毒性呼吸道感染的影响:快速综述。 (你原文中“of”后面缺少具体内容)

The effects of on viral respiratory infections in humans: A rapid review.

作者信息

Barnes Larisa Aj, Leach Matthew, Anheyer Dennis, Brown Danielle, Carè Jenny, Lauche Romy, Medina Daen N, Pinder Tobey-Ann, Bugarcic Andrea, Steel Amie

机构信息

University Centre for Rural Health, University of Sydney, Lismore, New South Wales, Australia.

National Centre for Naturopathic Medicine, Southern Cross University, Lismore, New South Wales, Australia.

出版信息

Adv Integr Med. 2020 Dec;7(4):222-226. doi: 10.1016/j.aimed.2020.07.012. Epub 2020 Aug 13.

Abstract

BRIEF OVERVIEW

Based on the evidence identified in this rapid review, preparations and herbal complex preparations including may be a therapeutic option for treating early symptoms of respiratory tract infections. The best effectiveness for preparations has been proven for coughing, as an expectorant and to reduce the frequency and intensity of cough. Only weak evidence was found for all other researched symptoms. Both adults and children tolerate well. Currently, there is insufficient evidence to recommend the use of this supplement in the treatment or prevention of COVID-19. However, the current evidence justifies further research to better understand its applicability in coronavirus infections.

VERDIC

tCurrent evidence suggests may improve the frequency and intensity of cough associated with viral respiratory infection. The overall applicability of additional findings is limited by the poorly defined outcome measures employed. However, studies focused explicitly on expectoration did report an increased conversion from dry to productive cough, and an improvement in expectoration amount, consistency and colour. These effects may be explained by a related finding of reduced oropharyngeal congestion and improved inflammatory markers (erythrocyte sedimentation rate and c-reactive protein). A decrease in frequency of night cough and respiratory pain was also reported, as was improved sleep quality and reduced cough-related sleep disturbance.Some studies also measured general respiratory tract infection symptoms and identified clinical improvement or resolution of fever, fatigue, sore throat, sneezing, wheezing, nasal congestion, post-nasal drip and body-ache. A reduced need for antibiotic prescriptions was also identified. While not consistently reported, the majority of studies also found reduced the overall severity of viral bronchitis and related conditions. Tolerability was rated as between 'good' and 'high'. Adverse events were rare or non-existent in almost all studies, and those that were reported were defined as non-serious and not drug-related.

摘要

简要概述

基于本次快速综述中确定的证据,包括[具体内容未给出]在内的制剂和草药复方制剂可能是治疗呼吸道感染早期症状的一种治疗选择。已证实该制剂在止咳方面效果最佳,可作为祛痰剂并减少咳嗽的频率和强度。对于所有其他研究的症状,仅发现了微弱的证据。成人和儿童对该制剂耐受性良好。目前,没有足够的证据推荐使用这种补充剂来治疗或预防新冠病毒。然而,目前的证据为进一步研究以更好地了解其在冠状病毒感染中的适用性提供了依据。

结论

目前的证据表明[具体内容未给出]可能改善与病毒性呼吸道感染相关的咳嗽频率和强度。其他研究结果的总体适用性受到所采用的结局指标定义不明确的限制。然而,明确聚焦于咳痰的研究确实报告了干咳转为湿咳的转化率增加,以及咳痰量、质地和颜色的改善。这些效果可能由口咽充血减轻和炎症标志物(红细胞沉降率和C反应蛋白)改善这一相关发现来解释。还报告了夜间咳嗽频率和呼吸疼痛的降低,以及睡眠质量的改善和与咳嗽相关的睡眠障碍的减少。一些研究还测量了一般呼吸道感染症状,并确定发热、疲劳、喉咙痛、打喷嚏、喘息、鼻塞、鼻后滴漏和身体疼痛有临床改善或缓解。还发现抗生素处方需求减少。虽然并非一直有报告,但大多数研究还发现[具体内容未给出]降低了病毒性支气管炎及相关病症的总体严重程度。耐受性被评为“良好”至“高”。几乎所有研究中不良事件都很少见或不存在,报告的不良事件被定义为不严重且与药物无关。

相似文献

1
The effects of on viral respiratory infections in humans: A rapid review.
Adv Integr Med. 2020 Dec;7(4):222-226. doi: 10.1016/j.aimed.2020.07.012. Epub 2020 Aug 13.
2
Ivy leaf (Hedera helix) for acute upper respiratory tract infections: an updated systematic review.
Eur J Clin Pharmacol. 2021 Aug;77(8):1113-1122. doi: 10.1007/s00228-021-03090-4. Epub 2021 Feb 1.
4
Delayed antibiotics for symptoms and complications of respiratory infections.
Cochrane Database Syst Rev. 2004 Oct 18(4):CD004417. doi: 10.1002/14651858.CD004417.pub2.
5
Assessment of the Efficacy and Safety of Ivy Leaf () Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis.
Evid Based Complement Alternat Med. 2020 May 4;2020:1910656. doi: 10.1155/2020/1910656. eCollection 2020.
6
The effects of berry on acute respiratory viral infections: A rapid review of clinical studies.
Adv Integr Med. 2020 Dec;7(4):240-246. doi: 10.1016/j.aimed.2020.08.001. Epub 2020 Aug 22.
7
Expectorant and antitussive effect of Hedera helix and Rhizoma coptidis extracts mixture.
Yonsei Med J. 2015 May;56(3):819-24. doi: 10.3349/ymj.2015.56.3.819.
8
[Clinical analysis of the first patient with imported Middle East respiratory syndrome in China].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Aug;27(8):630-4. doi: 10.3760/cma.j.issn.2095-4352.2015.08.002.
10
Systematic review of clinical trials assessing the effectiveness of ivy leaf (hedera helix) for acute upper respiratory tract infections.
Evid Based Complement Alternat Med. 2011;2011:382789. doi: 10.1155/2011/382789. Epub 2010 Oct 3.

引用本文的文献

5
Plant-Derived Natural Products as Lead Agents against Common Respiratory Diseases.
Molecules. 2022 May 10;27(10):3054. doi: 10.3390/molecules27103054.
7
Integrative health needs to engage with effective public health interventions on merit, not oppose them on them on principle.
Adv Integr Med. 2021 Dec;8(4):245-246. doi: 10.1016/j.aimed.2021.11.002. Epub 2021 Dec 8.

本文引用的文献

1
Assessment of the Efficacy and Safety of Ivy Leaf () Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis.
Evid Based Complement Alternat Med. 2020 May 4;2020:1910656. doi: 10.1155/2020/1910656. eCollection 2020.
2
Reduced antibiotic use after initial treatment of acute respiratory infections with phytopharmaceuticals- a retrospective cohort study.
Postgrad Med. 2020 Jun;132(5):412-418. doi: 10.1080/00325481.2020.1751497. Epub 2020 Apr 20.
3
Molecular immune pathogenesis and diagnosis of COVID-19.
J Pharm Anal. 2020 Apr;10(2):102-108. doi: 10.1016/j.jpha.2020.03.001. Epub 2020 Mar 5.
4
Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.
Int J Antimicrob Agents. 2020 Jun;55(6):105948. doi: 10.1016/j.ijantimicag.2020.105948. Epub 2020 Mar 19.
5
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
6
Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Lancet Respir Med. 2020 Apr;8(4):420-422. doi: 10.1016/S2213-2600(20)30076-X. Epub 2020 Feb 18.
8
RoB 2: a revised tool for assessing risk of bias in randomised trials.
BMJ. 2019 Aug 28;366:l4898. doi: 10.1136/bmj.l4898.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验